Achieve Life Sciences

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-57
-57
EBITDA
-12,105
-12,089
-7,600
-5,624
EBIT
-12,163
-12,146
-7,657
-5,681
Net Income
-12,360
-12,512
-8,461
-6,494
Net Change In Cash
0
0
0
0
Free Cash Flow
-9,189
-10,372
-4,921
-5,288
Cash
12,733
9,544
14,756
66,397
Basic Shares
32,071
34,355
34,318
25,048

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-228
-236
-250
EBITDA
-26,734
-40,564
-32,844
EBIT
-26,962
-40,800
-33,094
Net Income
-39,827
-29,815
-41,875
-32,902
Net Change In Cash
0
0
0
0
Cost of Revenue
-18,254
Free Cash Flow
-29,770
-24,500
-37,549
-29,457
Cash
12,753
15,546
24,771
43,022
Basic Shares
32,071
19,827
10,593
8,119

Earnings Calls

Quarter EPS
2024-12-31
-$0.36
2024-09-30
-$0.36
2024-06-30
-$0.25
2024-03-31
-$0.26